Literature DB >> 7641211

Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.

E P Sandgren1, J A Schroeder, T H Qui, R D Palmiter, R L Brinster, D C Lee.   

Abstract

Deregulated expression of transforming growth factor alpha (TGF-alpha) or c-myc has been implicated in the genesis of human breast cancer. To better characterize the role of these molecules in this disease, we generated transgenic mice that express TGF-alpha or c-myc under control of the mouse whey acidic protein (WAP) promoter. We then compared the resulting mammary gland neoplasia in these mice and in previously described mice expressing a metallothionein-driven TGF-alpha transgene. Nonvirgin female mice in all transgenic lineages developed mammary tumors with 100% incidence but variable latency. Among TGF-alpha lines, mean survival time correlated with the level of transgene expression, and the average life spans of high-expressing WAP-TGF-alpha and WAP-c-myc mice were similarly reduced. The majority of TGF-alpha-induced tumors were relatively well-differentiated adenomas and adenocarcinomas; in contrast, WAP-c-myc tumors were poorly differentiated, solid carcinomas with a minority of adenocarcinomas. Most TGF-alpha and all c-myc-induced tumors were transplantable, but lung metastases were infrequently observed in all transgenic lines. WAP-TGF-alpha-induced tumors, in marked contrast to those induced by WAP-c-myc, displayed frequent induction of cyclin D1 mRNA, suggesting that expression of this gene may complement that of TGF-alpha during mammary tumor development. Expression of TGF-alpha also induced precocious development of pregnant glands and delayed or inhibited mammary involution. As a result, multiparious MT-TGF-alpha and especially WAP-TGF-alpha females accumulated large numbers of hyperplastic alveolar nodules that resembled the more differentiated TGF-alpha-induced tumors. Finally, coexpression of WAP-c-myc and WAP-TGF-alpha transgenes markedly decreased tumor latency, increased tumor growth, and even induced mammary tumors in virgin female and male mice. These findings provide further evidence for the importance of deregulated TGF-alpha expression in multistage carcinogenesis, and they suggest that in the mammary gland the mechanism of TGF-alpha-induced transformation may depend on postlactational survival of differentiated epithelium. They also provide evidence of a potent tumorigenic collaboration between TGF-alpha and c-myc in mammary epithelium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641211

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

Review 1.  Regulation of p53 and its targets during involution of the mammary gland.

Authors:  D J Jerry; J Pinkas; C Kuperwasser; E S Dickinson; S P Naber
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

2.  Tumor suppressor function of Liver kinase B1 (Lkb1) is linked to regulation of epithelial integrity.

Authors:  Johanna I Partanen; Topi A Tervonen; Mikko Myllynen; Essi Lind; Misa Imai; Pekka Katajisto; Gerrit J P Dijkgraaf; Panu E Kovanen; Tomi P Mäkelä; Zena Werb; Juha Klefström
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-20       Impact factor: 11.205

3.  MYC-induced apoptosis in mammary epithelial cells is associated with repression of lineage-specific gene signatures.

Authors:  Heidi M Haikala; Juha Klefström; Martin Eilers; Katrin E Wiese
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

4.  Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma.

Authors:  Lixing Zhan; Avi Rosenberg; Kenneth C Bergami; Min Yu; Zhenyu Xuan; Aron B Jaffe; Craig Allred; Senthil K Muthuswamy
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

5.  STAT3-enhancing germline mutations contribute to tumor-extrinsic immune evasion.

Authors:  Daniel Kogan; Alexander Grabner; Christopher Yanucil; Christian Faul; Vijay Kumar Ulaganathan
Journal:  J Clin Invest       Date:  2018-04-03       Impact factor: 14.808

6.  Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells.

Authors:  Brenda R Baldwin; Nikolai A Timchenko; Cynthia A Zahnow
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 7.  Of mice and Myc: c-Myc and mammary tumorigenesis.

Authors:  M Hunter Jamerson; Michael D Johnson; Robert B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

8.  Mammary carcinogenesis is preceded by altered epithelial cell turnover in transforming growth factor-alpha and c-myc transgenic mice.

Authors:  Teresa A Rose-Hellekant; Kristin M Wentworth; Sarah Nikolai; Donald W Kundel; Eric P Sandgren
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

9.  Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis.

Authors:  Jeffrey W Schmidt; Barbara L Wehde; Kazuhito Sakamoto; Aleata A Triplett; Steven M Anderson; Philip N Tsichlis; Gustavo Leone; Kay-Uwe Wagner
Journal:  Mol Cell Biol       Date:  2014-01-27       Impact factor: 4.272

Review 10.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.